"Drug Hypersensitivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
| Descriptor ID |
D004342
|
| MeSH Number(s) |
C20.543.206 C25.100.468
|
| Concept/Terms |
Drug Hypersensitivity- Drug Hypersensitivity
- Drug Hypersensitivities
- Hypersensitivities, Drug
- Drug Allergy
- Allergies, Drug
- Drug Allergies
- Hypersensitivity, Drug
- Allergy, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Hypersensitivity".
Below are MeSH descriptors whose meaning is more specific than "Drug Hypersensitivity".
This graph shows the total number of publications written about "Drug Hypersensitivity" by people in this website by year, and whether "Drug Hypersensitivity" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 3 | 6 |
| 1996 | 3 | 2 | 5 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 5 | 1 | 6 |
| 2003 | 5 | 2 | 7 |
| 2004 | 1 | 3 | 4 |
| 2005 | 5 | 3 | 8 |
| 2006 | 5 | 2 | 7 |
| 2007 | 4 | 2 | 6 |
| 2008 | 1 | 3 | 4 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 3 | 4 |
| 2012 | 6 | 5 | 11 |
| 2013 | 5 | 2 | 7 |
| 2014 | 8 | 0 | 8 |
| 2015 | 7 | 3 | 10 |
| 2016 | 5 | 3 | 8 |
| 2017 | 11 | 1 | 12 |
| 2018 | 5 | 2 | 7 |
| 2019 | 8 | 0 | 8 |
| 2020 | 12 | 1 | 13 |
| 2021 | 10 | 1 | 11 |
| 2022 | 7 | 0 | 7 |
| 2023 | 9 | 0 | 9 |
| 2024 | 4 | 3 | 7 |
Below are the most recent publications written about "Drug Hypersensitivity" by people in Profiles.
-
Delayed drug reactions: The next frontier in drug allergy? Ann Allergy Asthma Immunol. 2024 Aug; 133(2):125-126.
-
Successful treatment of neurocysticercosis with albendazole desensitization. Asian Pac J Allergy Immunol. 2024 Jun; 42(2):176-179.
-
Allergenicity and marketing characteristics of 100 popular over-the-counter acne treatments. Arch Dermatol Res. 2024 May 25; 316(6):276.
-
Promoting prenatal penicillin allergy evaluations: A multi-year process improvement study. Ann Allergy Asthma Immunol. 2024 Jul; 133(1):107-109.
-
Sugammadex-Associated Anaphylaxis: Summary and Proposed Management. Anesth Analg. 2024 Aug 01; 139(2):273-277.
-
Rechallenges without desensitization following platinum-based chemotherapy reactions. J Oncol Pharm Pract. 2024 Apr; 30(3):572-575.
-
Desensitization using pegaspargase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization. Pediatr Blood Cancer. 2024 Apr; 71(4):e30891.
-
Hereditary alpha tryptasemia presenting as recurrent chemotherapy hypersensitivity reactions. Ann Allergy Asthma Immunol. 2024 03; 132(3):270-273.
-
Maternal penicillin allergy and infant outcomes: Results from a large administrative cohort. J Allergy Clin Immunol Pract. 2024 Apr; 12(4):1080-1082.e1.
-
Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side-by-side comparison. Pediatr Blood Cancer. 2024 Jan; 71(1):e30716.